https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-01 / Anticancer Res. 2015 Oct;35(10):5401-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-01 / Anticancer Res. 2015 Oct;35(10):5401-62015-10-01 00:00:002015-10-01 00:00:00Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-01 / Drug Discov Ther 2015 Oct;9(5):363-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-01 / Drug Discov Ther 2015 Oct;9(5):363-712015-10-01 00:00:002015-10-01 00:00:00Immunotherapy for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-01 / Pharmacol. Rev. 2015 Oct;67(4):731-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-01 / Pharmacol. Rev. 2015 Oct;67(4):731-532015-10-01 00:00:002019-02-15 08:45:13Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-01 / J. Immunother. 2015 Oct;38(8):330-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-01 / J. Immunother. 2015 Oct;38(8):330-92015-10-01 00:00:002019-02-15 08:51:17Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-29 / Oncotarget 2015 Sep;6(29):27751-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-29 / Oncotarget 2015 Sep;6(29):27751-622015-09-29 00:00:002019-02-15 08:52:37Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-15 / Oncotarget 2015 Sep;6(27):23462-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-15 / Oncotarget 2015 Sep;6(27):23462-792015-09-15 00:00:002019-02-15 08:52:37A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-14 / Int J Hyperthermia 2015;31(7):784-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-14 / Int J Hyperthermia 2015;31(7):784-922015-09-14 00:00:002019-03-27 11:37:15Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e1083669
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e10836692015-09-11 00:00:002021-11-15 13:26:23Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-10 / Bioimpacts 2015;5(3):117-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-10 / Bioimpacts 2015;5(3):117-222015-09-10 00:00:002019-02-15 08:46:12A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-08 / Oncol. Rep. 2015 Nov;34(5):2656-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-08 / Oncol. Rep. 2015 Nov;34(5):2656-642015-09-08 00:00:002019-02-15 09:33:31Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer
